Sign in to continue:

Tuesday, March 31st, 2026

Day: March 17, 2026

Agenus Inc. 2025 Annual Report: Immuno-Oncology Strategy, Lead Programs, and Recent Developments

Introduction Agenus Inc. (Nasdaq: AGEN), a biotechnology ...

Investors Title Company 2025 Annual Report: Business Overview, Risk Factors, and Cybersecurity Strategy

Investors Title Company 2025 Annual Report: In-Depth Analysi...